V
VelarionIntelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

UFP Technologies Executive Compensation (FY25)

UFPT · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (8-K): June 5, 2026
150 figures on this page: 148 cited to the filing that reported them, 2 calculated from figures it prints. See the citations
R. Jeffrey Bailly, Chief Executive Officer, received $7,648,440 in total compensation for fiscal 2025, and Bailly's total was 45.0% higher than the $5,276,527 reported for fiscal 2024. The disclosed chief executive pay ratio for fiscal 2025 is 1,031:1, against median employee compensation of $7,416. Shareholders supported the say-on-pay proposal with 90.0% of votes cast for or against in favor at the meeting held June 4, 2026 for fiscal 2025. Companies named in the disclosed peer group include 10X Genomics, Inc., Alphatec Holdings, Inc., AtriCure, Inc., Avanos Medical, Inc and Azenta, Inc., among others.
Chief executive, fiscal 2025
R. Jeffrey Bailly
Latest say-on-pay support
=
June 4, 2026
Chief executive pay ratio
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — R. Jeffrey Bailly: $5,276,527$7,648,440 (45.0% higher)
Say-on-pay support: 87.7%90.0% (2.3 points higher)
CEO pay ratio: 909:11,031:1 (13.4% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is UFP Technologies' chief executive and what were they paid?
R. Jeffrey Bailly, Chief Executive Officer, received $7,648,440 in total compensation for fiscal 2025. Bailly's total was 45.0% higher than the $5,276,527 reported for fiscal 2024.
What was UFP Technologies' say-on-pay result?
Shareholders supported the say-on-pay proposal with 90.0% of votes cast for or against in favor at the meeting held June 4, 2026 for fiscal 2025.
Which companies are in UFP Technologies' peer group?
Companies named in the disclosed peer group include 10X Genomics, Inc., Alphatec Holdings, Inc., AtriCure, Inc., Avanos Medical, Inc and Azenta, Inc., among others.
What is UFP Technologies' chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 1,031:1, against median employee compensation of $7,416.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
R. Jeffrey Bailly
Chief Executive Officer
Ronald Lataille
Senior Vice President, Treasurer, and Chief Financial Officer
Mitchell Rock
President
Christopher Litterio
General Counsel, Secretary, and Senior Vice President of Human Resources
Jason Holt
Senior Vice President
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
R. Jeffrey Bailly
Chief Executive Officer
Mitchell Rock
President
Ronald Lataille
Senior Vice President, Treasurer, and Chief Financial Officer
Christopher Litterio
General Counsel, Secretary, and Senior Vice President of Human Resources
Jason Holt
Senior Vice President
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
R. Jeffrey Bailly
Chief Executive Officer
Mitchell Rock
President
Ronald Lataille
Senior Vice President, Treasurer, and Chief Financial Officer
Christopher Litterio
General Counsel, Secretary, and Senior Vice President of Human Resources
Jason Holt
Senior Vice President
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Christopher P. LitterioPSU
Jason HoltPSU
Mitchell C. RockPSU
R. Jeffrey BaillyRSU
R. Jeffrey BaillyPSU
Ronald J. LataillePSU
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Jason HoltRSU
Mitchell RockRSU
R. BaillyRSU
Ronald LatailleRSU
Christopher LitterioRSU
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Daniel C. Croteau
Lead independent director
Cynthia L. Feldmann
Joseph John Hassett
Symeria Hudson
Thomas Oberdorf
Marc Kozin
R. Jeffrey Bailly served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer
Board equity retainer
Total board retainer
Lead independent director premium
Audit committee chair
Audit committee member
Compensation committee chair
Compensation committee member
Equity is delivered as restricted stock units.
Stock ownership guideline: 3x annual base cash retainer fee

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • 10X Genomics, Inc. TXG
  • Alphatec Holdings, Inc. ATEC
  • AtriCure, Inc. ATRC
  • Avanos Medical, Inc AVNS
  • Azenta, Inc. AZTA
  • CONMED Corporation CNMD
  • Glaukos Corporation GKOS
  • Haemonetics Corporation HAE
  • Inari Medical, Inc. (now Stryker) NARI
  • Integer Holdings Corporation ITGR
  • Integra Life Sciences Holding Corp. IART
  • iRhythm Technologies, Inc. IRTC
  • Novanta, Inc. NOVT
  • Orthofix Medical, Inc. OFIX
  • Osi Systems, Inc. OSIS
  • Sotera Health Company SHC
  • STAAR Surgical Company STAA
  • Transmedics Group, Inc. TMDX

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 4, 2026=
2024June 4, 2025=

Chief executive pay ratio

As calculated and reported by the company.
Ratio
Median employee compensation
Chief executive total compensation
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when UFP Technologies files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact UFP Technologies disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where UFP Technologies sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether UFP Technologies' disclosed peer group is defensible, who names UFP Technologies back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
150 figures on this page: 148 cited to the filing that reported them, 2 calculated from figures it prints.
148 cited to the filing
2 calculated from the filing

Documents cited

  1. 0001628280-26-041108
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001628280-26-028710
    CEO Pay Ratio · DIRECTOR COMPENSATION · Grants of Plan-Based Awards—2025 · Outstanding Equity Awards at Fiscal 2025 Year‑End · and 1 more section
  3. 0001171843-25-003753
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001171843-25-002638
    SUMMARY COMPENSATION TABLE
  5. 0001171843-24-002290
    SUMMARY COMPENSATION TABLE
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “UFP Technologies executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/UFPT (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about UFP Technologies and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive payMedTech & DiagnosticsCEO pay ratioMedTech & DiagnosticsSay-on-pay supportMedTech & Diagnostics

Peers UFP Technologies discloses

The companies named in UFPT's own disclosed peer group.

10X Genomics, Inc.AtriCure, Inc.Avanos Medical, IncAzenta, Inc.CONMED CorporationGlaukos CorporationHaemonetics CorporationInteger Holdings CorporationIntegra Life Sciences Holding Corp.iRhythm Technologies, Inc.Orthofix Medical, Inc.Osi Systems, Inc.STAAR Surgical Company

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy